Edition:
United States

Profile: Sterling Biotech Ltd (STBI.NS)

STBI.NS on National Stock Exchange of India

4.65INR
5:59am EDT
Change (% chg)

Rs0.05 (+1.09%)
Prev Close
Rs4.60
Open
Rs4.70
Day's High
Rs4.70
Day's Low
Rs4.45
Volume
103,481
Avg. Vol
197,646
52-wk High
Rs7.90
52-wk Low
Rs2.95

Sterling Biotech Limited is an India-based pharmaceutical company. The Company is engaged into manufacturing gelatin from animal bones. The Company produces various pharmaceutical products, such as Lovastatin, a cholesterol lowering drug, and oncology products. Its anti-cancer products include DOXO Rubicin, an anti-cancer chemotherapy drug; IDARUBICIN, an anti-cancer (antineoplastic or cytotoxic) chemotherapy drug; Daunorubicin, which is used to treat acute lymphocytic and myelocyticleukemias; IMATINIB, a drug used to treat certain cancers, and EPI Rubicin, an anthracycline drug used for chemotherapy. The Company's other products include DACARBAZINE, which is used to treat Hodgkin disease and malignant melanoma; Temozolamide, an oral alkylating agent used for the treatment of Grade IV astrocytoma, and Simvastatin, a lipid lowering drug. Its plants are located at Village Karakhadi and Village Masar in Gujarat, and Sandyanalla, Sholur Gram Panchayat in Tamilnadu.

Company Address

Sterling Biotech Ltd

C - 25, Laxmi Towers, 'A' - 601,
Bandra Kurla Complex, Bandra (Ea
MUMBAI     400051
P: +9122.26541241
F: +9122.26540155

Company Web Links